Skip to search formSkip to main contentSkip to account menu

SU 11654

Known as: SU-11654, SU11654 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Spontaneous cancers are common in the pet dog population with estimated 60% of dogs that live to 10 years of age developing… 
2010
2010
Toceranib phosphate (Palladia, SU11654), an oral tyrosine-kinase inhibitor, is under investigation for the treatment of mast cell… 
Review
2010
Review
2010
Toceranib phosphate (Palladia, SU11654), a multireceptor tyrosine kinase inhibitor with anti-tumor and anti-angiogenic activity… 
Review
2010
Review
2010
Spontaneous cancers occur commonly in the pet dog population. Indeed, an estimated 60% of dogs that live to 10 years of age will… 
2009
2009
In this issue of Clinical Cancer Research , London and colleagues report on the evaluation of a small molecule multiple-targeted… 
2006
2006
OBJECTIVE To evaluate canine histiocytic sarcoma cell lines and tumor samples for dysregulation of the Kit/stem-cell factor (SCF…